Lexicon Pharmaceuticals (LXRX) Change in Inventory (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Change in Inventory of -$5000.0 for Q1 2026, up 83.33% year-over-year from -$2727.3 in Q1 2025, and down 104.07% quarter-over-quarter from $123000.0 in Q4 2025.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Change in Inventory (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Change in Inventory for 8 consecutive years, with -$5000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 83.33% year-over-year to -$5000.0; the TTM figure through Mar 2026 stood at $75000.0 (up 123.96% YoY), while the FY2025 annual figure was $50000.0, up 133.33% from the prior year.
- Change in Inventory slipped to -$5000.0 in Q1 2026 per LXRX's latest filing, from $123000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $172000.0 in Q2 2023 and bottomed at -$405000.0 in Q4 2024.
- Historically, Change in Inventory has averaged $23000.0 across 4 years, with a median of $48000.0 in 2023.
- Annual changes were most pronounced in 2024 — Change in Inventory slumped 1000.0% — and 2025, when it jumped 130.37%.
- Lexicon Pharmaceuticals' Change in Inventory stood at $45000.0 in 2023, then plunged by 1000.0% to -$405000.0 in 2024, then surged by 130.37% to $123000.0 in 2025, then sank by 104.07% to -$5000.0 in 2026.
- Business Quant data shows LXRX's Change in Inventory at -$5000.0 in Q1 2026, $123000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 | 920,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 920,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Dec 31, 2024 | -405,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 71,000.00 |
| Mar 31, 2024 | 133,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 164,000.00 |
| Jun 30, 2023 | 172,000.00 |
| Sep 30, 2020 | -91,000.00 |
| Jun 30, 2020 | -158,000.00 |
| Mar 31, 2020 | -96,000.00 |
| Dec 31, 2019 | -233,000.00 |
| Sep 30, 2019 | 199,000.00 |
| Jun 30, 2019 | -329,000.00 |
| Mar 31, 2019 | -74,000.00 |